Oncology Nutrition Market Size & Share 2024 - 2032

Oncology Nutrition Market Size

Oncology Nutrition Market size was valued at USD 2.1 billion in 2023 growing at a CAGR of 8.1% between 2024 and 2032, driven by factors such as the rising global prevalence of cancer that fuels the demand for specialized nutritional products and services to support cancer patients before, during, and after treatment.

For instance, as per the report published by World Health Organization in February 2024, it has been reported that, in 2022, the estimated number of people who were alive within 5 years following a cancer diagnosis was 53.5 million. In addition, about 1 in 5 people develop cancer in their lifetime. Thus, the rapid increase in the prevalence of cancer globally is expected to increase the demand for nutrition products that propel the growth of the market in upcoming years.
 

Moreover, the growing awareness of nutrition in cancer management to manage side effects, improve treatment tolerance, and enhance quality of life during cancer therapy is expected to boost the market growth. Oncology nutrition focuses on providing a balanced and tailored diet for cancer patients, essential for supporting overall health, enhancing recovery, and managing the side effects of cancer treatments. It is based on increasing the patient’s intake of protein and calories with small amounts of hot or cold food that is highly nutritious and easy to digest.

Oncology Nutrition Market Trends

• The rising prevalence of cancer worldwide is a significant driver for the market. As the number of cancer patients increases, the demand for specialized nutrition products and services tailored to meet the nutritional needs of cancer patients rises. For instance, as per the report published by World Health Organization in July 2023 breast cancer and lung cancer is among the leading cause of cancer-related deaths worldwide. Also, the report stated that, more than 1.9 million new cases of colorectal cancer and more than 930 000 deaths due to colorectal cancer were estimated to have occurred worldwide. Therefore, such a rapid rise in the prevalence of cancer will increase the early cancer diagnostic and treatment along with nutritional care, thereby propelling the market growth.
   
• Moreover, cancer patients often experience malnutrition due to various factors such as reduced appetite, side effects of treatment, metabolic changes, and the presence of the tumor. Thus, proper nutrition plays a crucial role in managing cancer-related malnutrition, supporting the immune system, and improving treatment outcomes.
   

Oncology nutrition Market Analysis

Based on the cancer type, the global market is classified into head and neck cancer, stomach and gastrointestinal cancer, esophageal cancer, liver cancer, breast cancer, pancreatic cancer, lung cancer, and other cancer types. The stomach and gastrointestinal cancer segment dominated the market with revenue of USD 472 million in 2023.
 

• The rise in the prevalence of gastrointestinal cancer, owing to poor dietary habits such as high consumption of processed foods, red meats, and low intake of fruits and vegetables rises the demand for specialized nutrition to support patients undergoing treatment also increases.
   
• Moreover, with the rise in awareness about nutritional support, the adoption of specialized nutrition products tailored to the needs of cancer patients, including those with stomach and gastrointestinal cancers increases.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on the product type, the global oncology nutrition market is classified into vitamins and minerals, proteins, antioxidants, and other product types. The proteins segment dominated the market with market share of 33.5% in 2023.
 

• With the increase in prevalence of cancer, healthcare providers are increasingly recognizing the importance of nutritional support as part of cancer treatment. Protein-rich diets are often recommended to help maintain muscle mass, prevent weight loss, and support overall health during cancer therapy.
   
• Additionally, companies in the healthcare and nutrition sectors are continually innovating to develop new and improved oncology nutrition products tailored to the specific needs of cancer patients. This includes protein supplements formulated with optimal nutrient compositions and flavors to enhance palatability.
   

Based on formulation, the oncology nutrition market is classified into standard and elemental. Standard segment is expected to exhibit 8.5% CAGR between 2024 - 2032.
 

• Developed to fulfill precise needs, standard oncology nutrition formulas are crafted to supply vital nutrients and calories essential for sustaining overall health and wellness. Consequently, heightened awareness regarding the role of adequate nutrition in mitigating side effects of cancer treatment, enhancing quality of life, and improving treatment outcomes has emerged among individuals. This underscores the importance of tailored oncology nutrition formulas designed to meet these needs, particularly for elderly cancer patients, thereby driving market expansion in the foreseeable future.
   

Based on route of administration, the oncology nutrition market is classified into oral and parenteral. Oral segment is expected to reach 2.6 billion by 2032.
 

• The surge in technological advancement has led to the development of oral nutritional supplements with enhanced palatability, better absorption, and increased nutrient content, making them more appealing and effective for cancer patients. Also, many patients prefer oral nutritional supplements over alternative routes like parenteral (intravenous) nutrition due to convenience and ease of administration, which can drive the demand for oral products.
   

Based on dosage type, the oncology nutrition market is classified into liquid, powder, and other dosage types. Liquid segment accounted with market share of 42.1% in 2023.
 

• Patients with cancer often experience gastrointestinal issues such as nausea, vomiting, or mucositis, which can make swallowing solid dosage forms challenging. Therefore, in such cases liquid dosage form provide better compliance absorbed more quickly and efficiently by the body compared to solid forms, ensuring patients receive vital nutrients, thereby augmenting the growth of the market in the coming years.
   

Based on end-use, the oncology nutrition market is classified into hospitals, clinics, homecare, and other end-users. Hospitals segment is expected to exhibit 8.5% CAGR between 2024 - 2032.
 

• With the rise in prevalence of cancer, hospitals witness a growing number of cancer patients seeking treatment, necessitating specialized nutrition interventions to support their health during treatment and recovery. Thus, the hospitals are increasingly focusing on providing comprehensive care for cancer patients, including nutrition support as an integral part of treatment plans. This emphasis drives the demand for oncology nutrition services within hospital settings, thereby fostering the segmental growth. 
   

In 2023, North America secured a substantial market share of 42.7% in the global market and is expected to dominate throughout the forecast period.
 

• Supportive care initiatives in North America prioritize enhancing patient outcomes for those suffering with cancer. Therefore, nutrition plays a crucial role in such care, resulting in an increased need for specialized oncology nutritional interventions.
   
• Furthermore, governmental efforts and healthcare policies in North America underscore the significance of comprehensive cancer care, encompassing nutritional support.
   

Oncology Nutrition Market Share

The competitive landscape of the market is characterized by the presence of established pharmaceutical and nutraceutical companies that manufacture nutritional products vying for market share. Key players are engaging in strategic initiatives such as acquisitions, product launch, investment, and partnerships to strengthen their product portfolio.
 

Oncology Nutrition Market Companies

Prominent players operating in the market are as mentioned below:

• Abbott Laboratories
• Baxter International Inc.
• B. Braun Melsungen AG
• Danone (Nutricia)
• Fresenius SE & Co. KGaA
• Grifol S.A.
• Hormel Foods Corporation
• Meiji Holdings Co., Ltd.
• Medtrition Inc.
• Nestle S.A.
• Victus, Inc.
   

Oncology Nutrition Industry News:

• In January 2024, Danone partners with digital oncology company Resilience, a remote patient care solution, for better nutritional care for patients with cancer. The partnership aims to develop the first of its kind nutrition and oncology module that is now integrated in Resilience’s digital oncology solution. This strategy is expected to enhance their long-term business relations along with innovative product development.
   
• In April 2020, Esperer Onco Nutrition launched a range of nutrition supplements catered to the needs of cancer patients. This includes a set of three products targeting the needs of cancer patients with different stages of the cancer treatment. This strategy enabled company to add value to its existing business portfolio.
   

The oncology nutrition market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Cancer Type

• Head and neck cancer
• Stomach and gastrointestinal cancer
• Esophageal cancer
• Liver cancer
• Breast cancer
• Pancreatic cancer
• Lung cancer
• Other cancer types

Market, By Product type

• Vitamins and minerals
• Proteins
• Antioxidants
• Other product types

Market, By Formulation

• Standard
• Elemental

Market, By Route of administration

• Oral
• Parenteral

Market, By Dosage type

• Liquid
• Powder
• Other dosage types

Market, By End-use

• Hospitals
• Clinics
• Homecare
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudia Arabia
  • Rest of Middle East and Africa